http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015112099-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0601d923869481b0d51082e7f620581
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-44
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-20
filingDate 2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_318412720ee8bfef019247e3af4d5ea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a2c7760a57e5c23df1fcedb27be7a6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28d234b37b68bfd78023db97a95c095
publicationDate 2015-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015112099-A1
titleOfInvention Production of immunoreactive proteins by using the methods of recombinant dna technology that usable for serological diagnosis of babesia ovis infection
abstract Invention relates to the production of immunoreactive proteins obtained from Babesia ovis organisms by using the methods of recombinant DNA technology. The specific genes encoding these proteins were detected with immunoscreening of cDNA library constructed from mRNA of Babesia ovis. After cloning of these specific genes in the pGEX expression vectors, recombinant vectors were transformed to the competent E. coli cells for expression of recombinant proteins. The proteins were expressed as GST-fusion proteins in E. coli cells with IPTG induction, and were purified by glutathione affinity chromatography. The results of ELISA using these GST-fusion proteins as antigens showed that the two immunoreactive proteins detected B. ovis-specific antibodies in the eighth day of experimental infection.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108315341-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110082534-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018372742-A1
priorityDate 2014-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013117763-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID237579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582658
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID237580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID237579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129192845
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID237580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9983292
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228953845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21389
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9940
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9940
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656894
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562

Total number of triples: 48.